HF
UPB

HRT Financial’s Upstream Bio Inc UPB Stock Holding History

HRT Financial’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
+170,590
New +$1.43M ﹤0.01% 2065

Other funds holding UPB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HRT Financial's UPB Position: Q2 2026 in Review

HRT Financial opened a new position in Upstream Bio Inc (UPB) in Q2 2026: 170,590 shares worth $1.18M. The stake represents ﹤0.01% of the portfolio and ranks #2065 among its holdings.

150 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • HRT Financial held 170,590 shares of Upstream Bio Inc worth $1.18M as of Q2 2026.
  • Upstream Bio Inc was a new HRT Financial position in Q2 2026.
  • Upstream Bio Inc made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2065 holding.
  • 150 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.